ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.005,07
-0,11%
Brent Oil
83,76
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Petros Pharmaceuticals Inc (PTPI)

  7. Petros Pharmaceuticals Inc (PTPI) Notícias

PTPI

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTPI
DataHoraFonteTítuloCódigoCompanhia
14/05/202408:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202418:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202319:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202318:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202318:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202319:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202319:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202317:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202318:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202318:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202317:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202317:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202319:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
22/12/202219:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202210:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202209:03Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:PTPIPetros Pharmaceuticals Inc
21/10/202207:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTPIPetros Pharmaceuticals Inc
14/10/202217:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/10/202218:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
30/09/202217:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/08/202218:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202212:39GlobeNewswire Inc.NOTICE TO DISREGARD - Henry Crown and CompanyNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202211:27GlobeNewswire Inc.Petros Pharmaceuticals Responds to Fraudulent Press ReleaseNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202210:25GlobeNewswire Inc.Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per shareNASDAQ:PTPIPetros Pharmaceuticals Inc
19/07/202210:15GlobeNewswire Inc.Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew PinskyNASDAQ:PTPIPetros Pharmaceuticals Inc
16/05/202218:00GlobeNewswire Inc.Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:PTPIPetros Pharmaceuticals Inc
03/05/202210:23GlobeNewswire Inc.Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the USNASDAQ:PTPIPetros Pharmaceuticals Inc
27/04/202222:25GlobeNewswire Inc.Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022NASDAQ:PTPIPetros Pharmaceuticals Inc
26/04/202210:15GlobeNewswire Inc.Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor TechnologyNASDAQ:PTPIPetros Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTPI

Seu Histórico Recente

TSXV
OMT
ASX
GBX
Gb Energy
TSX
DFN
Dividend 15 Split
TSXV
BLM
BluMetric Environmental
TSXV
GCV.P
Golden Star Capital Vent...
TSXV
MGR
Magna Gold
LSE
ARGP
TSXV
JEN.H
LSE
0O45
Ls Telcom
TSX
SES
Secure Energy Services
TSXV
PI
NYSE
MITT
AG Mortgage Investment
ASX
CRB
Carbine Resources
BOV
EQPA5
EQTL PARA PNA
TSXV
ESC.H
NYSE
WU
Western Union
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados